Encaleret acts on the calcium-sensing receptor to help ADH1 patients … for investors to buy right now… and BridgeBio Pharma, Inc. wasn’t one of them. … Named President of the New Jersey Intellectual Property Law Association.
Encaleret acts on the calcium-sensing receptor to help ADH1 patients … for investors to buy right now… and BridgeBio Pharma, Inc. wasn’t one of them. … Named President of the New Jersey Intellectual Property Law Association.